Viewing Study NCT01014468

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2026-05-06 @ 2:50 PM
Study NCT ID: NCT01014468
Status: UNKNOWN
Last Update Posted: 2011-11-22
First Post: 2009-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration
Sponsor: Instituto de Olhos de Goiania
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Age Related Macular Degeneration View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ranibizumab View
None bevacizumab View
None AMD View
None Complications View
None Visual acuity View
None OCt View
None Age Macular Degeneration View